News & Press: Latest News

Early Stage Device Funding Decreases in Q2 2014, Late Stage Funding Increases

Friday, August 22, 2014  
Posted by: Sheri DeVinney
Share |

Early Stage Device Funding Decreases in Q2 2014, Late Stage Funding Increases

A new MoneyTree report analysis was released recently by PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA). The report found that venture capitalists in the United States invested $2.5 billion in the life sciences during the second quarter of 2014. This compares with $2.0 billion during the same quarter in 2013.

Venture Capital funding of medical device companies varied when comparing this year’s second quarter numbers with those during the same quarter in 2013. Second quarter funding for early-stage device companies decreased in 2014 when comparing 2013 numbers; however, funding for late-stage companies increased this year according to the analysis.

Early-stage device funding decreased 10 percent, while late-stage funding increased to 41% during the past quarter of this year when compared with 2013. Average deal size during the second quarter of 2014 equaled $7.1 million for early-stage companies and $9.8 million for late-stage companies. To view the report, please click here.